Companies: 10,795·Total market cap: $144.5T
Innovent Biologics, Inc.

Innovent Biologics, Inc.

IVBXFOTCHealthcare● Active
$9.10
$-0.99(-9.85%)
Market Cap$15.8B
P/E Ratio
52W High$15.12
52W Low$9.01
Overview

Innovent Biologics, Inc. (IVBXF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IVBXF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$0.43ivbxf eps ttm · ivbxf earnings per shareEarnings history
PE Ratio (TTM)21.3×ivbxf pe ratio ttm · ivbxf price to earningsPE Ratio deep dive
Revenue (TTM)$22.3Bivbxf revenue ttm · ivbxf annual revenueFull revenue history
Dividend YieldNo Dividenddoes ivbxf pay dividends · ivbxf dividend yieldDividend history
Shares Outstanding1.68Bivbxf shares outstanding · ivbxf floatShares outstanding history
Next EarningsAug 26, 2026Est.ivbxf earnings date · ivbxf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$12.70B▲ +34.85% YoY
202320242025
innovent biologics, inc. revenue · ivbxf revenue 2025
FY 2025Net Income$792.6M▲ +937.54% YoY
202320242025
innovent biologics, inc. net income · ivbxf profit 2025
FY 2025EPS$0.47▲ +908.95% YoY
202320242025
ivbxf eps · innovent biologics, inc. earnings per share 2025
TTM:Revenue: $22.35BNet Income: $719.3MEPS: $0.43View income statement →

Stock Performance

Full History
1D-9.85%
1W-11.13%
1M-11.65%
3M-8.54%
YTD-6.67%
1Y-9.72%
5Y-18.75%

About Innovent Biologics, Inc.

CEODe-Chao Yu
IPO DateSep 4, 2019
Employees5,659
CountryCN

Innovent Biologics, Inc. is a biopharmaceutical firm headquartered in Suzhou, People's Republic of China, established in 2011. It specializes in the discovery, advancement, and production of antibody-…

what is innovent biologics, inc. · ivbxf stock overview · innovent biologics, inc. company profile · who is innovent biologics, inc. ceo · ivbxf OTC · innovent biologics, inc. headquarters · innovent biologics, inc. business segments

About Stock Overview & Key Data

Innovent Biologics, Inc. (IVBXF) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 4, 2019. As of the latest trading session, IVBXF stock price is $9.10, with a market capitalization of $15.8B. The stock has returned -9.72% over the past 12 months and -6.67% year-to-date.

In fiscal year 2025, Innovent Biologics, Inc. reported revenue of $12.7B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Innovent Biologics, Inc. (IVBXF) stock price is $9.10. The stock is traded on OTC under the ticker symbol IVBXF. The 52-week range is $9.01 – $15.12.

IVBXF stock priceIVBXF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice